Buscar
Mostrando ítems 1-10 de 72
Acceptability of a herd immunity-focused, transmission-blocking malaria vaccine in malaria-endemic communities in the Peruvian Amazon: an exploratory study
(BioMed Central, 2018)
BACKGROUND: A transmission-blocking vaccine (TBV) to prevent malaria-infected humans from infecting mosquitoes has been increasingly considered as a tool for malaria control and elimination. This study tested the hypothesis ...
MEFAS, a hybrid of artesunate-mefloquine active against asexual stages of Plasmodium vivax in field isolates, inhibits malaria transmission
(Elsevier, 2021)
Human malaria continues to be a public health problem and an important cause of morbidity and mortality in the world. Malaria control is achieved through both individual protection against mosquito bites and drug treatment, ...
Socio-demographics and the development of malaria elimination strategies in the low transmission setting
(Elsevier, 2012)
This analysis presents a comprehensive description of malaria burden and risk factors in Peruvian Amazon villages where malaria transmission is hypoendemic. More than 9000 subjects were studied in contrasting village ...
Primaquina, gametocitemia de Plasmodium falciparum y bloqueo de transmisión: ineficacia del actual régimen de dosificación
(Universidad Autónoma de Bucaramanga UNAB, 2012-08-10)
Antecedentes: Los esquizonticidas anti-Plasmodium schizontocides falciparum reducen la gametocitemia, sin erradicarla; por ello, se adiciona primaquina (PQ). Esta se administra al terminar el esquizonticida: día 4; 0,75 ...
Human host-derived cytokines associated with Plasmodium vivax transmission from acute malaria patients to Anopheles darlingi mosquitoes in the Peruvian Amazon
(American Society of Tropical Medicine and Hygiene, 2013)
Infection of mosquitoes by humans is not always successful in the setting of patent gametocytemia. This study tested the hypothesis that pro- or anti-inflammatory cytokines are associated with transmission of Plasmodium ...
A purification methodology for viable and infective Plasmodium vivax gametocytes compatible with transmission blocking assays
(American Society for Microbiology, 2016)
Worldwide sequence conservation of transmission-blocking vaccine candidate Pvs230 in Plasmodium vivax
(ELSEVIER SCI LTD, 2011)
Pfs230, surface protein of gametocyte/gamete of the human malaria parasite, Plasmodium falciparum, is a prime candidate of malaria transmission-blocking vaccine. Plasmodium vivax has an ortholog of Pfs230 (Pvs230), however, ...